Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 229
Filtrar
1.
Arch Mal Coeur Vaiss ; 97(11): 1130-4, 2004 Nov.
Artigo em Francês | MEDLINE | ID: mdl-15609916

RESUMO

In 2004, surgery for cardiac arrhythmias addresses essentially atrial fibrillation. Surgery is only a rare alternative for other cardiac arrhythmias in center that still have the surgical skill. Surgery for atrial fibrillation has the definite advantage of concomitant exclusion of the left atrial appendage which is the predominant site of intra-atrial thrombi with the associated risk of severe thrombo-embolic events. Our experience with surgery for lone atrial fibrillation, using the Corridor III operation, shows that surgery is associated with high efficacy and long term control of arrhythmia when the surgical technique is well performed. Failures were associated with incomplete line of block or exclusion. This experience shows the necessity of postoperative EP testing. Initially performed using open heart technique, surger for atrial fibrillation is now performed using mini-invasive technique. Indications for surgery for lone atrial fibrillation will decreased while other strategies are developing. To remain competitive surgery must have high efficacy and use mini-invasive techniques. i.e.: closed off pump beating heart via port access. Surgery for atrial fibrillation concomitant with other cardiac surgical repairs yields remarkable results, without increased surgical risk. Their indications go beyond mitral valve pathology. Future developments imply the following conditions: atrial surgery must not increase morbidity, and its cost-effectiveness must be documented. Combined surgery must be testable and tested to gain valid pathophysiological data to improve surgical rationales. Its impact in terms of survival, prevention of thrombo-embolic events and quality of life will be documented by clinical trials.


Assuntos
Fibrilação Atrial/cirurgia , Ablação por Cateter , Procedimentos Cirúrgicos Cardiovasculares , Humanos , Fatores de Risco , Tromboembolia/etiologia , Tromboembolia/prevenção & controle , Resultado do Tratamento
2.
Ann Thorac Surg ; 71(3 Suppl): S166-70; discussion S183-4, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11265854

RESUMO

BACKGROUND: Ventricular assist devices have been shown to be effective as bridges to transplantation and recovery for patients with end-stage heart failure. Current technology has been limited because of the need for percutaneous connections with controllers. The HeartSaver ventricular assist device (VAD) (World Heart Corporation, Ottawa, Ontario, Canada) was developed with the intention of having a completely implantable, portable VAD system. The system consists of an electrohydraulic blood pump, internal and external battery power, and a transcutaneous energy transfer and telemetry unit that allows for power transmission through the skin. Control of the device may be achieved locally or remotely through a variety of communication systems. METHODS: The device has been modified with the Series II preclinical version being available for in vitro (mock loop) and in vivo (bovine model) testing. RESULTS: Seventeen Series II devices have been functional on mock loops or other testing trials for an accumulated 900 days of operation. There have been eight acute experiments using a bovine model to test various components as they have become available from manufacturing. Mean pump output was 10.4 +/- 1.1 L/min in full-fill/full-eject mode. Changes in the last 24 months include (1) cannula redesign for better port alignment and integration of tissue valves; (2) battery redesign to convert to new lithium-ion cells; (3) optimized infrared information and electromagnetic inductance energy transmission through various skin thicknesses and pigmentation; and (4) improved reliability of internal and external controller hardware and software. CONCLUSIONS: Modifications have been required to optimize the HeartSaver VAD's performance. The final HeartSaver VAD design will be produced in the near future to allow for formal in vitro and in vivo testing before clinical implantation.


Assuntos
Insuficiência Cardíaca/cirurgia , Coração Auxiliar , Animais , Desenho de Equipamento , Humanos , Implantação de Prótese/métodos
3.
J Cardiovasc Electrophysiol ; 11(2): 199-202, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10709715

RESUMO

This report describes a 33-year-old patient with arrhythmogenic right ventricular (RV) dysplasia who had a dual chamber pacemaker implanted at age 23 years for drug-induced bradycardia. Pacing was continued after right ventricular free-wall disconnection (RVFWD) at age 24 years. Her pacemaker was not replaced after battery depletion 7 years later. She presented the following year in severe right-sided heart failure. Her old pacemaker generator was replaced. This was followed by rapid resolution of her clinical failure and return to a full, active, physical lifestyle. This observation suggests the potential benefit of dual chamber pacing in patients with RV dysplasia after RVFWD.


Assuntos
Displasia Arritmogênica Ventricular Direita/terapia , Estimulação Cardíaca Artificial , Procedimentos Cirúrgicos Cardíacos , Adulto , Displasia Arritmogênica Ventricular Direita/cirurgia , Baixo Débito Cardíaco/diagnóstico por imagem , Baixo Débito Cardíaco/etiologia , Baixo Débito Cardíaco/fisiopatologia , Estimulação Cardíaca Artificial/efeitos adversos , Ecocardiografia , Eletrocardiografia , Desenho de Equipamento , Falha de Equipamento , Feminino , Ventrículos do Coração/cirurgia , Humanos , Marca-Passo Artificial , Período Pós-Operatório
4.
J Cardiovasc Electrophysiol ; 10(8): 1162-70, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10466499

RESUMO

Current nomenclature for the AV junctions derives from a surgically distorted view, placing the valvar rings and the triangle of Koch in a single plane with anteroposterior and right-left lateral coordinates. Within this convention, the aorta is considered to occupy an anterior position, whereas the mouth of the coronary sinus is shown as being posterior. Although this nomenclature has served its purpose for the description and treatment of arrhythmias dependent on accessory pathways and AV nodal reentry, it is less than satisfactory for the description of atrial and ventricular mapping. To correct these deficiencies, a consensus document has been prepared by experts from the Working Group of Arrhythmias of the European Society of Cardiology and from the North American Society of Pacing and Electrophysiology. It proposes a new, anatomically sound, nomenclature that will be applicable to all chambers of the heart. In this report, we discuss its value for description of the AV junctions and establish the principles of this new nomenclature.


Assuntos
Nó Atrioventricular/anatomia & histologia , Mapeamento Potencial de Superfície Corporal , Terminologia como Assunto , Humanos
5.
Circulation ; 100(5): e31-7, 1999 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-10430823

RESUMO

Current nomenclature for the atrioventricular (AV) junctions derives from a surgically distorted view, placing the valvar rings and the triangle of Koch in a single plane with antero-posterior and right-left lateral coordinates. Within this convention, the aorta is considered to occupy an anterior position, although the mouth of the coronary sinus is shown as being posterior. Although this nomenclature has served its purpose for the description and treatment of arrhythmias dependent on accessory pathways and atrioventricular nodal reentry, it is less than satisfactory for the description of atrial and ventricular mapping. To correct these deficiencies, a consensus document has been prepared by experts from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. It proposes a new anatomically sound nomenclature that will be applicable to all chambers of the heart. In this report, we discuss its value for description of the AV junctions, establishing the principles of this new nomenclature.


Assuntos
Nó Atrioventricular/anatomia & histologia , Fascículo Atrioventricular/anatomia & histologia , Terminologia como Assunto , Ablação por Cateter , Fluoroscopia , Sistema de Condução Cardíaco/anatomia & histologia , Sistema de Condução Cardíaco/diagnóstico por imagem , Humanos , Valva Mitral/anatomia & histologia , Valva Tricúspide/anatomia & histologia
6.
Eur Heart J ; 20(15): 1068-75, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10413636

RESUMO

Current nomenclature for atrioventricular junctions derives from a surgically distorted view, placing the valvar rings and the triangle of Koch in a single plane with antero-posterior and right-left lateral coordinates. Within this convention, the aorta is considered to occupy an anterior position, while the mouth of the coronary sinus is shown as being posterior. While this nomenclature has served its purpose for the description and treatment of arrhythmias dependent on accessory pathways and atrioventricular nodal re-entry, it is less than satisfactory for the description of atrial and ventricular mapping. To correct these deficiencies, a consensus document has been prepared by experts from the Working Group of Arrhythmias of the European Society of Cardiology, and the North American Society of Pacing and Electrophysiology. It proposes a new, anatomically sound, nomenclature that will be applicable to all chambers of the heart. In this report, we discuss its value as regards the description of the atrioventricular junctions, establishing the principles of this new nomenclature.


Assuntos
Nó Atrioventricular/anatomia & histologia , Superfície Corporal , Terminologia como Assunto , Cateterismo Cardíaco , Humanos
7.
Eur Heart J ; 20(7): 527-34, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10365289

RESUMO

AIMS: Although arrhythmia surgery and radiofrequency catheter ablation to cure atrioventricular nodal reentrant tachycardia differ in technical concept, the late results of both methods, in terms of elimination of the arrhythmogenic substrate and procedure-related new and different arrhythmias, have never been compared. This constituted the purpose of this prospective follow-up study. METHODS AND RESULTS: Between 1988 and 1992, 26 patients were surgically treated using perinodal dissection or 'skeletonization', and from 1991 up to 1995, 120 patients underwent radiofrequency modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. The acute success rates of surgery and radiofrequency catheter ablation were 96% and 92%, respectively. Late recurrence, rate in the surgical and radiofrequency catheter ablation groups was 12% and 17%, respectively. Mean follow-up was 53 months in the surgical group and 28 months in the radiofrequency catheter ablation group. The final success rate after repeat intervention was 100% in the surgical group and 98% in the radiofrequency catheter ablation group. Comparison of the initial and recent series of radiofrequency catheter ablated patients showed an increased initial success rate with fewer applications. In the radiofrequency catheter ablation group, a second- or third-degree block developed in three patients (2%), requiring permanent pacing, whereas in the surgical group no complete atrioventricular block was observed. Inappropriate sinus tachycardia needing drug treatment was observed in 13 patients (11%), mostly after fast pathway ablation, but was never observed after surgery. New and different supraventricular tachyarrhythmias arose in 27% of the patients in the surgical group and in 11% of the radiofrequency catheter ablation group, but did not clearly differ. CONCLUSION: This one-institutional follow-up study demonstrated comparable initial and late success rates as well as incidence of new and different supraventricular arrhythmias following arrhythmia surgery and radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia. Today radiofrequency catheter ablation has replaced arrhythmia surgery for various reasons, but the late arrhythmic side-effects warrant refinement of technique.


Assuntos
Nó Atrioventricular/cirurgia , Procedimentos Cirúrgicos Cardíacos , Ablação por Cateter , Taquicardia por Reentrada no Nó Atrioventricular/cirurgia , Adulto , Nó Atrioventricular/fisiopatologia , Ponte Cardiopulmonar , Eletrocardiografia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Taquicardia por Reentrada no Nó Atrioventricular/fisiopatologia , Resultado do Tratamento
8.
Pacing Clin Electrophysiol ; 21(11 Pt 2): 2160-5, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9825311

RESUMO

Cardiac surgeons took to the heart and claimed an exclusive privilege to intervene. The task of cardiologists was to identify "candidates" and feed the Great Surgical Machine. Recently catheter surgery has developed and fell into the hands of cardiologists, who became interventionists. Cardiac surgeons are concerned about losing interventions and their identify. The analysis of the current situation implies a revisitation of old concepts: surgery, intervention, therapy, patients, invasiveness etc ... etc ... and a review of our therapeutic philosophy. Therapeutic plans comprise three interrelated components: the target, the bullet (therapeutic agent), and the gun (the way of delivering the bullet on target). This description characterizes surgery as a way of delivering. If side effects are effects that do not affect the target, surgical procedures are mostly side effects, with significant morbidity. Future surgical rationales should reconcile target-specific therapy and minimal collateral damages: Minimal Surgery! or to use a new buzz, less invasiveness. Cardiac surgery has focused too much on surgical practice and neglected the rest of cardiology, missing opportunities for new researches, new rationales, and new techniques. Surgeons must become again Renaissance Men, involved in the entire field of cardiology, with a special skill in surgical techniques. Cardiac surgeons should no longer confine their practice to the delivering end. This end does not, any more, justify the means.


Assuntos
Radiologia Intervencionista , Cirurgia Torácica , Atitude do Pessoal de Saúde , Procedimentos Cirúrgicos Cardíacos/tendências , Ablação por Cateter , Humanos
9.
J Card Surg ; 13(2): 156-62, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10063966

RESUMO

Cardiac surgeons took to the heart and claimed an exclusive privilege to intervene. The task of cardiologists was to identify "candidates" and feed the great surgical machine. Recently, catheter surgery was developed and has fallen into the hands of cardiologists who became interventionists. Cardiac surgeons are concerned about shrinking domain, identity, and the future. The analysis of the current situation requires another look at old concepts: surgery, intervention, therapy, patients, invasiveness, etc., and a revision of the philosophy of the entire profession. Therapeutic plans comprise three interrelated components: the target, the bullet (therapeutic agent), and the gun (the way of delivering the bullet on target ). This description characterizes surgery as a way of delivering. If side effects are effects that do not affect the target, surgical procedures are mostly side effects, with significant morbidity. Future surgical rationales should reconcile target-specific therapy and minimal collateral damages: "minimal surgery!" or to use a new buzzword, "less invasive surgery." Cardiac surgery has focused on surgical practice and neglected the science of cardiology, missing opportunities for new research, new rationales, new techniques, and new territories. Surgeons must again become Renaissance men, involved in the entire field of cardiology, with a special skill in surgical techniques. Cardiac surgeons should no longer confine their practice to the delivering end. This end does not, any more, justify the means.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Cirurgia Torácica , Humanos
10.
J Cardiovasc Electrophysiol ; 8(9): 967-73, 1997 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9300292

RESUMO

INTRODUCTION: Currently, surgery- and catheter-mediated ablation is applied when drug refractoriness of atrial fibrillation is evident, although little is known about the long-term incidence of new atrial arrhythmia and the preservation of sinus node function. METHODS AND RESULTS: To address this issue, 30 patients with successful corridor surgery for lone paroxysmal atrial fibrillation and normal preoperative sinus node function were followed in a single outpatient department. Five years after surgery, the actuarial proportion of patients with recurrence of atrial fibrillation arising in the corridor was 8% +/- 5%, with new atrial arrhythmias consisting of atrial flutter and atrial tachycardia in the corridor 27% +/- 8%, and with incompetent sinus node requiring pacing therapy 13% +/- 6%. Right atrial transport was preserved in 69% of the patients without recurrence of atrial fibrillation and normal sinus node function. Stroke was documented in two patients. CONCLUSIONS: Corridor surgery for atrial fibrillation is a transient or palliative treatment instead of a definitive therapy for drug refractory atrial fibrillation. This observation strongly affects patient selection for this intervention and constitutes a word of caution for other, nonpharmacologic interventions for drug refractory atrial fibrillation.


Assuntos
Fibrilação Atrial/complicações , Fibrilação Atrial/cirurgia , Complicações Pós-Operatórias/etiologia , Adulto , Arritmias Cardíacas/fisiopatologia , Fibrilação Atrial/fisiopatologia , Função do Átrio Direito/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Marca-Passo Artificial , Complicações Pós-Operatórias/fisiopatologia , Estudos Prospectivos , Recidiva , Nó Sinoatrial/fisiopatologia , Tromboembolia/fisiopatologia , Fatores de Tempo
11.
Ann Thorac Surg ; 64(6): 1718-23; discussion 1723-4, 1997 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9436561

RESUMO

BACKGROUND: Right ventricular (RV) dysfunction is common after heart transplantation, and myocardial ischemia is considered to be a significant contributor. We studied whether intraaortic balloon counterpulsation would improve cardiac function using a model of acute RV pressure overload. METHODS: In 10 anesthetized sheep, RV failure was induced using a pulmonary artery constrictor. Baseline measurements included mean systemic blood pressure, RV peak systolic pressure, cardiac index, and RV ejection fraction. Myocardial and organ perfusion were measured using radioactive microspheres. RESULTS: After pulmonary artery constriction, there was an increase in RV peak systolic pressure (32 +/- 2 to 60 +/- 3 mm Hg; p < 0.01) and a decrease in mean systemic blood pressure (68 +/- 4 to 49 +/- 2 mm Hg; p < 0.01), RV ejection fraction (0.51 +/- 0.04 to 0.16 +/- 0.02; p < 0.01), and cardiac index (2.48 +/- 0.04 to 1.02 +/- 0.11; p < 0.01). Blood flow to the RV did not change significantly, but there was a significant reduction in blood flow to the left ventricle. The initiation of intraaortic balloon counterpulsation (1:1) using a 40-mL intraaortic balloon inserted through the left femoral artery resulted in an increase in mean systemic blood pressure (49 +/- 2 to 61 +/- 3 mm Hg; p < 0.01), cardiac index (1.02 +/- 0.11 to 1.45 +/- 0.14; p < 0.05), RV ejection fraction (0.16 +/- 0.02 to 0.23 +/- 0.02; p < 0.01), and blood flow to the left ventricle. CONCLUSIONS: In a model of right heart failure, the institution of intraaortic balloon counterpulsation caused a significant improvement in cardiac function. Although RV ischemia was not demonstrated, the augmentation of left coronary artery blood flow by intraaortic balloon counterpulsation and subsequent improvement in left ventricular function suggest that left ventricular ischemia contributes to RV dysfunction, presumably through a ventricular interdependence mechanism. Therefore, study of the safety and efficacy of intraaortic balloon counterpulsation in the management of patients with acute right heart dysfunction is warranted.


Assuntos
Balão Intra-Aórtico , Disfunção Ventricular Direita/terapia , Animais , Pressão Sanguínea , Circulação Coronária , Modelos Animais de Doenças , Artéria Pulmonar/fisiologia , Ovinos , Volume Sistólico , Disfunção Ventricular Direita/etiologia
12.
Pacing Clin Electrophysiol ; 19(11 Pt 2): 1933-8, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8945072

RESUMO

We report our experience with seven patients who underwent direct surgical ablation of problematic common flutter. Intraoperative mapping was obtained in four patients. Surgical techniques varied over time. A circular incision of the right atrium was performed in the first patient. Two patients had epicardial cryoablation of the isthmus between the inferior vena cava and the tricuspid valve annulus. Four patients had extensive endocardial cryoablation of the isthmus. There were no immediate postoperative complications. One patient had atrial fibrillation 2 months postoperatively and underwent a corridor operation 1 year later. The other six patients are free of arrhythmias without antiarrhythmic drugs. Surgical ablation confirmed that the common form of atrial flutter is associated with a right atrial macroreentrant circuit. One of our intraoperative endocardial maps suggested that variant reentrant circuits can be associated with variant forms of flutter.


Assuntos
Flutter Atrial/cirurgia , Adulto , Idoso , Fibrilação Atrial/etiologia , Flutter Atrial/etiologia , Flutter Atrial/fisiopatologia , Função do Átrio Direito , Mapeamento Potencial de Superfície Corporal , Ablação por Cateter/efeitos adversos , Criocirurgia , Eletrocardiografia , Endocárdio/cirurgia , Seguimentos , Átrios do Coração/inervação , Átrios do Coração/fisiopatologia , Átrios do Coração/cirurgia , Sistema de Condução Cardíaco/fisiopatologia , Sistema de Condução Cardíaco/cirurgia , Humanos , Cuidados Intraoperatórios , Masculino , Pessoa de Meia-Idade , Pericárdio/cirurgia , Complicações Pós-Operatórias , Reoperação , Valva Tricúspide/cirurgia , Veia Cava Inferior/cirurgia
13.
J Card Surg ; 11(6): 428-31, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9083870

RESUMO

BACKGROUND: Mobile right atrial thrombus is an uncommon finding on two-dimensional (2D) echocardiography. Therapeutic alternatives include systemic heparinization, systemic or local thrombolysis, and surgical removal. We report our clinical experience in six patients over a 3-year period (6000 echocardiograms) at a tertiary care referral center. METHODS: There were four men and two women with a mean age of 63 years (range: 47 to 73 years). Indications for echocardiography consisted of progressive dyspnea and chest pain in five patients and syncope with chest pain in one patient. RESULTS: All were observed to have a mobile thrombus in the right atrium. Ventilation perfusion (V/Q) scanning confirmed V/Q mismatch in all patients. Subsequent echocardiography (minutes to 1 day later) in three patients demonstrated absence of the thrombus suggesting pulmonary embolization. One patient died during transesophageal echocardiography (TEE) and autopsy confirmed a large pulmonary embolization in the main pulmonary artery. Treatment consisted of heparinization in 3 patients, systemic thrombolysis in 1 patient, and surgical removal of the thrombus in 1 patient. At surgery, a long serpiginous thrombus was seen in the right atrium, tethered to a fenestrated eustachian valve. There were 3 deaths: 1 patient treated with heparin; 1 patient treated with thrombolysis; and 1 during TEE. Two of the three patients treated with heparin and one patient undergoing surgical removal survived hospitalization. CONCLUSIONS: Mobile thrombus in the right atrium is an unusual echocardiographic finding. It portends a poor prognosis with death due to pulmonary embolism.


Assuntos
Cardiopatias/diagnóstico por imagem , Cardiopatias/terapia , Trombose/diagnóstico por imagem , Trombose/terapia , Idoso , Ecocardiografia , Feminino , Fibrinolíticos/uso terapêutico , Átrios do Coração , Heparina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Trombectomia , Terapia Trombolítica , Ativador de Plasminogênio Tecidual/uso terapêutico
14.
Arch Mal Coeur Vaiss ; 89 Spec No 1: 123-7, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8734173

RESUMO

1995 is the fifth anniversary of the advent of catheter ablation for the treatment of supraventricular tachycardia. Surgery has established the principles of the interventional approaches: 1) identification of the mechanism; 2) localization of the site of the mechanism; 3) identification of the anatomical arrhythmogenic substrate and its localization using preoperative and intraoperative electrophysiological cardiac mapping; 4) ablation of the arrhythmogenic substrate using "surgical" dissection or excision or various forms of energy to neutralize the substrate: cryoablation, laser, etc. Surgical approaches also established the EP interventions as the first line of therapy because they are curative. Currently, surgery for supraventricular tachycardia is essentially confined to atrial fibrillation, and after attempted catheter ablation for the Wolff-Parkinson-White syndrome. Atrial fibrillation is a complex arrhythmia, commonly associated with structural heart disease. To understand atrial fibrillation, a number of premises should be reviewed: atrial functional anatomy, atrial pathology, atrial fibrillation mechanism (s) and clinical presentation. The role of atrial fibrillation in terms of symptoms, morbidity and mortality is not clear because it is difficult to determine if atrial fibrillation is a symptom, a marker, an autonomous disease albeit it is in most cases an aggravating factor. Surgical rationales for atrial fibrillation are based on three concepts: exclusion, fragmentation and channelling. The Corridor operation was the first used direct surgical approach. The Maze operation and other techniques (fragmentation, spiral) have been reported. All surgical techniques have been reported with good results in terms of sinus node function and exercise tolerance, and to various degrees, in terms of atrial contraction. Currently, there is a trend to combine direct atrial fibrillation surgery with surgery for mitral valve albeit beneficial effects are not documented.


Assuntos
Ablação por Cateter/métodos , Sistema de Condução Cardíaco/cirurgia , Taquicardia Supraventricular/cirurgia , Fibrilação Atrial/cirurgia , Procedimentos Cirúrgicos Cardíacos , Átrios do Coração/fisiopatologia , Sistema de Condução Cardíaco/fisiopatologia , Humanos , Taquicardia por Reentrada no Nó Atrioventricular/cirurgia , Taquicardia Supraventricular/fisiopatologia , Falha de Tratamento , Resultado do Tratamento , Síndrome de Wolff-Parkinson-White/cirurgia
15.
J Card Surg ; 10(4 Pt 1): 295-7, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7549185

RESUMO

Latissimus dorsi cardiomyoplasty is a promising surgical therapy in some patients with congestive heart failure. Although the mortality in heart failure patients is attributable primarily to heart failure and ventricular arrhythmias, the mechanism of death after cardiomyoplasty is not well characterized. We describe the clinical course of a patient undergoing cardiomyoplasty and discuss the role of combined use with an implantable cardioverter defibrillator. A 39-year-old man with congestive heart failure due to a massive anterior wall myocardial infarction was evaluated for latissimus dorsi cardiomyoplasty. The patient was in NYHA Functional Class III due to heart failure. He did not have any significant exertional or rest angina. During a Naughton stress test, the patient could exercise for 10 minutes, achieving 4 METS. Pulmonary function study showed a peak V O2 of 22.1 mL/min per kg. Radionuclide angiography demonstrated that the anterior wall was akinetic with a left ventricular ejection fraction of 22%. Cardiac hemodynamic studies suggested moderate pulmonary hypertension, elevated wedge pressure, and suboptimal response to exercise. A Holter recording showed frequent ventricular extrasystoles. Cardiomyoplasty was preferred to heart transplantation because the patient did not have end-stage heart failure. Postoperatively, the patient required low doses of dopamine. He developed recurrent, sustained, and hemodynamically significant episodes of ventricular tachycardia. He was treated with a combination of amiodarone and procainamide. He died 2 days postoperatively with ventricular fibrillation. Ventricular arrhythmias are a major cause of death in patients with heart failure. Latissimus dorsi cardiomyoplasty appears to be a promising but unproven therapy in such patients.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Cardiomioplastia , Desfibriladores Implantáveis , Insuficiência Cardíaca/cirurgia , Adulto , Evolução Fatal , Humanos , Masculino , Complicações Pós-Operatórias , Taquicardia Ventricular/etiologia
16.
Can Assoc Radiol J ; 46(3): 226-8, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7538888

RESUMO

The authors describe a previously unreported complication of insertion of an automatic implantable cardioverter-defibrillator via the left subcostal surgical approach. Splenic hematoma, intraperitoneal hemorrhage and hypotension developed in a 66-year-old man within 5 days of implantation, and the patient underwent splenectomy.


Assuntos
Desfibriladores Implantáveis/efeitos adversos , Ruptura Esplênica/etiologia , Idoso , Humanos , Masculino , Ruptura Esplênica/diagnóstico por imagem , Tomografia Computadorizada por Raios X
18.
Pacing Clin Electrophysiol ; 17(11 Pt 2): 2156-62, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7845835

RESUMO

Surgical ablation of ventricular tachycardia is generally guided by the results of pre- and intraoperative cardiac mapping. However, in certain situations intraoperative cardiac mapping may not be possible and, therefore, surgery has to be based on information obtained preoperatively. This raises the question whether intraoperative mapping is necessary for the success of this approach. We describe our experience with encircling endocardial cryoablation for ischemic VT and examine the contribution of intraoperative mapping for this procedure. Thirty-three patients with inducible VT refractory to medical therapy and a well defined anatomic scar were considered for surgery. All patients underwent baseline electrophysiology study and intraoperative mapping was attempted during normothermic cardiopulmonary bypass. In 14 patients, VT was inducible intraoperatively (Group 1) and surgical ablation was guided by this information, whereas in 19 patients, VT could not be mapped for various reasons (Group 2). Reasons for failure to obtain intraoperative map included noninducibility (3), nonsustained VT (8), polymorphic VT (4), VF (3), and incessant VT with hemodynamic collapse and cardiac arrest (1). The two groups did not differ with respect to age, location of myocardial infarction, or preoperative left ventricular ejection fraction. The operative procedures were similar in the two groups with respect to aortic cross clamp time, cardiopulmonary bypass time, number of cryoablation lesions, concomitant revascularization, aneurysmectomy, and ICD implantation. Encircling endocardial cryoablation was performed in 32 patients and one patient underwent partial right ventricular free wall disconnection (RV infarct). Thirteen patients underwent concomitant coronary artery bypass grafting (5 in Group 1 and 8 in group 2). One patient had prophylactic ICD patches (Group 1).(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Criocirurgia , Eletrocardiografia , Taquicardia Ventricular/cirurgia , Estimulação Cardíaca Artificial , Ponte Cardiopulmonar , Angiografia Coronária , Endocárdio/fisiopatologia , Endocárdio/cirurgia , Feminino , Humanos , Período Intraoperatório , Masculino , Pessoa de Meia-Idade , Taxa de Sobrevida , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/mortalidade , Taquicardia Ventricular/fisiopatologia , Função Ventricular Esquerda
19.
Am Heart J ; 128(5): 982-9, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7942492

RESUMO

Encircling endocardial cryoablation, consisting of circumferential cryoablation of the infarct scar, can be curative in selected patients with ventricular tachycardia (VT). We describe our experience with and long-term outcome in 33 patients undergoing this procedure. The interval between myocardial infarction and the onset of tachycardia varied from 2 weeks to 22 years (mean 38 +/- 63 months and median 3 months). All patients had a left ventricular aneurysm (anterior in 20, posterior in 12, and lateral in 1) and significant coronary artery disease. Fourteen patients had clinical evidence of heart failure preoperatively. Twenty-eight patients had sustained monomorphic VT (incessant in 3); 3 had polymorphic or nonsustained tachycardia; 2 had primary ventricular fibrillation; and 1 had associated Wolff-Parkinson-White syndrome. Surgery was undertaken after failed drug therapy and consideration of left ventricular anatomy and function. At surgery, 32 patients had encircling endocardial cryoablation, and 1 patient had partial right ventricular free-wall disconnection (right ventricular infarct). Thirteen patients underwent concomitant coronary artery bypass grafting. An implantable cardioverter defibrillator (ICD) was implanted in 2 patients and prophylactic ICD patches in 1. One patient died postoperatively; 3 had recurrent VT perioperatively; 1 was treated with amiodarone; and 2 had ICD implantation. During long-term follow-up (mean 5 years), all patients who were free of tachycardia at discharge remained alive and free of arrhythmias or syncope. The patient receiving amiodarone sustained a cardiac arrest subsequently and received an ICD implant. One patient with an ICD continued to receive appropriate shocks frequently and died 2 years after surgery. Nine patients had congestive heart failure postoperatively.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Criocirurgia , Endocárdio/cirurgia , Infarto do Miocárdio/complicações , Taquicardia Ventricular/etiologia , Taquicardia Ventricular/cirurgia , Análise Atuarial , Feminino , Seguimentos , Aneurisma Cardíaco/cirurgia , Sistema de Condução Cardíaco/fisiopatologia , Humanos , Cuidados Intraoperatórios , Masculino , Pessoa de Meia-Idade , Taquicardia Ventricular/mortalidade , Fatores de Tempo , Resultado do Tratamento , Função Ventricular Esquerda/fisiologia
20.
Ann Thorac Surg ; 58(4): 1254-61, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7944801

RESUMO

The surgical treatment of the Wolff-Parkinson-White syndrome made its appearance in 1968 when Dr W. C. Sealy performed the first direct surgical intervention for ablating an accessory connection in a patient with incessant atrioventricular reentrant tachycardia. The surgical approach fell into disfavor in 1990 when catheter ablation using radiofrequency energy was adopted into widespread use. In this presentation, I will attempt to assess the scientific value of the surgical experience using the scholarly tool, the "retrospectroscope," and also to answer the questions, Was it worth it? What was learned? and What was achieved? We conclude that a large body of scientific knowledge and skill was brought to light by this experience and, of even more importance, passed on for best use to the catheter surgeons.


Assuntos
Sistema de Condução Cardíaco/cirurgia , Síndrome de Wolff-Parkinson-White/cirurgia , Ablação por Cateter , Coração/anatomia & histologia , Sistema de Condução Cardíaco/anormalidades , Humanos , Valva Tricúspide/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...